AstraZeneca Pharma and Rossari Biotech are flashing fresh breakout signals on strong Q1 metrics. Analyst Gunjan Kumar sees AstraZeneca forming an ascending triangle, advising a watch above Rs 9,350. Rossari, backed by increased FII/DII stakes, shows a trendline breakout above Rs 715. Both firms reported their best revenue in 13 quarters.